Adaptation and Validation of Frailty Scales in Intensive Care Units in Spain
2 other identifiers
observational
512
1 country
1
Brief Summary
Increased life expectancy leads to population aging, increased morbidities and aging of hospitalized patients. The acquisition of frailty leads to worse outcomes derived from hospitalization, but although frailty has been related to aging, young patients admitted to Intensive Care Units (ICU) with frailty have also been found to have worse outcomes than non-frail patients. This unfavorable evolution could be related to the acquisition of the post-uci syndrome (physical, mental and cognitive sequelae at discharge from the ICU), since high frailty scores favor this syndrome. The use of frailty scales on admission to the ICU could provide early detection of patients most likely to develop post-ICU syndrome, regardless of age, and redirect our care to those who need it most. Some scales that measure frailty in elderly patients have been used in the ICU, but although they have been validated in their original language, they need to be adapted and validated in Spanish. Objectives. Adaptation and validation of the Clinical Frailty Scale (CFS) and the FRAIL Scale in ICU patients of different ages, in women and in men. Methodology. Study developed in two phases.Phase 1, adaptation to Spanish of the scales (translation, pilot, back-translation, correlation); Phase 2, analysis of their metric properties (Validity, Reliability, Sensitivity, Minimum important difference) by means of a multicenter observational study (7 ICUs in Spain), prospective, descriptive, of a cohort of critical patients with one-year follow-up (at 3, 6, 9 and 12 months after hospital discharge).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 15, 2019
CompletedFirst Submitted
Initial submission to the registry
March 25, 2021
CompletedFirst Posted
Study publicly available on registry
April 5, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 5, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 5, 2024
CompletedMarch 13, 2025
March 1, 2025
5.1 years
March 25, 2021
March 10, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Fragility scales's validation
100% scale sensitivity
2 years
Secondary Outcomes (6)
Obtaining adapted scales to patients in intensive care units in Spain
6 months
Obtaining adapted scales to patients in intensive care units in Spain
6 months
Assessment of the predictive, convergent and divergent validity of the scales obtained (with respect to the original ones)
2 years
Assessment of the interobserver and intraobserver reliability of the scales obtained (with respect to the original ones)
2 years
Assessment of the sensitivity to change of the scales obtained (with respect to the original ones)
1 year
- +1 more secondary outcomes
Eligibility Criteria
All patients who remain hospitalized for more than 48 hours in any of the 8 Spanish intensive care units participating in the study, they will be candidates for inclusion in the study.
You may qualify if:
- \- Critical care patients over 18 years who have given their consent personally.
You may not qualify if:
- Patients admitted with a diagnosis of present or imminent brain death,
- readmissions previously included,
- patients whose expected stay is less than 48 hours
- patients with comunication problems
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hospital Universitario Getafelead
- Instituto de Salud Carlos IIIcollaborator
Study Sites (1)
Hospital Universitario de Getafe
Getafe, Madrid, 28905, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 12 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 25, 2021
First Posted
April 5, 2021
Study Start
September 15, 2019
Primary Completion
October 5, 2024
Study Completion
October 5, 2024
Last Updated
March 13, 2025
Record last verified: 2025-03